Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Reader Login
Users Online :3047
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2017| October-December  | Volume 54 | Issue 4  
    Online since July 30, 2018

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
HEAD AND NECK/OUTCOMES
Outcomes of surgically treated oral cancer patients at a tertiary cancer center in India
Deepa Nair, Hitesh Singhvi, Manish Mair, Burhanuddin Qayyumi, Anuja Deshmukh, Gouri Pantvaidya, Sudhir Nair, Pankaj Chaturvedi, Sarbani Ghosh Laskar, Kumar Prabhash, Anil DCruz
October-December 2017, 54(4):616-620
DOI:10.4103/ijc.IJC_445_17  PMID:30082545
  2 1,350 188
CASE REPORTS AND LETTERS
Chylothorax in children with cancer: A milky predicament
Sidharth Totadri, Amita Trehan, Anish Bhattacharya, Deepak Bansal, Savita Verma Attri, Radhika Srinivasan
October-December 2017, 54(4):691-694
DOI:10.4103/ijc.IJC_499_17  PMID:30082560
  1 1,016 113
CNS/OUTCOMES
Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unit
Tejpal Gupta, Sridhar Epari, Aliasgar Moiyadi, Prakash Shetty, Jayant Sastri Goda, Rahul Krishnatry, Girish Chinnaswamy, Tushar Vora, Hari Menon, Vijay Patil, Ayushi Sahay, Nazia Bano, Rakesh Jalali
October-December 2017, 54(4):594-600
DOI:10.4103/ijc.IJC_543_17  PMID:30082541
  1 1,160 142
GI ONCOLOGY/EPIDEMIOLOGY
Gallbladder cancer incidence in Delhi urban: A 25-year trend analysis
Rajeev Kumar Malhotra, Nalliah Manoharan, NK Shukla, Gourva Kishore Rath
October-December 2017, 54(4):673-677
DOI:10.4103/ijc.IJC_393_17  PMID:30082556
  1 1,478 178
GI ONCOLOGY/MEDICAL ONCOLOGY/RADIATION
Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature
Arvind Krishnamurthy, N Mohanraj, Venkataraman Radhakrishnan, Alexander John, G Selvaluxmy
October-December 2017, 54(4):646-651
DOI:10.4103/ijc.IJC_452_17  PMID:30082551
  1 1,169 132
GI ONCOLOGY/SURGERY
Cervical esophago-gastric anastomosis using linear cutter stapler in esophageal cancer
Parth Kanaiyalal Patel, Mishal Shah, Sanjeev Patni, Shashikant Saini
October-December 2017, 54(4):669-672
DOI:10.4103/ijc.IJC_381_17  PMID:30082555
  1 1,140 134
GI ONCOLOGY/SURGERY/OUTCOMES
Radical gastrectomy for gastric cancer at Tata Memorial Hospital
Manish S. Bhandare, Naveena AN Kumar, Swati Batra, Vikram Chaudhari, Shailesh V Shrikhande
October-December 2017, 54(4):605-608
DOI:10.4103/ijc.IJC_665_17  PMID:30082543
  1 1,986 134
LUNG CANCER
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive cases
Saurabh Zanwar, Vanita Noronha, Amit Joshi, Vijay M Patil, Rajiv Kaushal, Anuradha Chougule, Amit Janu, Abhishek Mahajan, Akhil Kapoor, Kumar Prabhash
October-December 2017, 54(4):678-680
DOI:10.4103/ijc.IJC_532_16  PMID:30082557
  1 911 123
NOSOCOMIAL INFECTIONS
Antibiotic/adjuvant combinations (ceftriaxone + sulbactam + adjuvant disodium edetate) as an alternative empiric therapy for the treatment of nosocomial infections: Results of a retrospective study
Saibal Chakravorty, Prashant Arun
October-December 2017, 54(4):685-690
DOI:10.4103/ijc.IJC_364_17  PMID:30082559
  1 1,470 169
BREAST CANCER
Molecular subtypes as a predictor of response to neoadjuvant chemotherapy in breast cancer patients
Shanmugam Subbiah, Govindasamy Gopu, P Senthilkumar, P Muniasamy
October-December 2017, 54(4):652-657
DOI:10.4103/ijc.IJC_238_17  PMID:30082552
  - 1,229 173
Triple-negative breast cancers: Are they always different from nontriple-negative breast cancers? An experience from a tertiary center in India
Suhani, Rajinder Parshad, Mufaddal Kazi, V Seenu, Sandeep Mathur, Siddharth Dattagupta, KP Haresh
October-December 2017, 54(4):658-663
DOI:10.4103/ijc.IJC_348_17  PMID:30082553
  - 1,786 164
A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer
Prasad Apsangikar, Sunil Chaudhry, Manoj Naik, Shashank Deoghare, Jamila Joseph
October-December 2017, 54(4):664-668
DOI:10.4103/ijc.IJC_449_17  PMID:30082554
  - 1,757 223
CASE REPORTS AND LETTERS
Eccrine spiradenoma: A rare adnexal tumor
Singh Kanwaljeet, Tathagatta Chatterjee
October-December 2017, 54(4):695-696
DOI:10.4103/ijc.IJC_301_17  PMID:30082561
  - 1,466 135
Surendra Nath Sehgal: A pioneer in rapamycin discovery
Debopam Samanta
October-December 2017, 54(4):697-698
DOI:10.4103/ijc.IJC_84_18  PMID:30082562
  - 1,027 89
Medial plantar artery perforator flap for reconstruction of the soft tissue defect of heel melanoma
Parth Kanaiyalal Patel, Shikha Tewari, Nitin Khunteta
October-December 2017, 54(4):699-700
DOI:10.4103/ijc.IJC_197_17  PMID:30082563
  - 893 112
EDITORIAL
Public reporting of healthcare data – Need of the hour in India
RA Badwe
October-December 2017, 54(4):592-593
DOI:10.4103/ijc.IJC_358_18  PMID:30082540
  - 1,017 132
GI ONCOLOGY/MEDICAL ONCOLOGY
Safety and antitumor activity of arsenic trioxide plus infusional 5-fluorouracil, leucovorin, and irinotecan as second-line chemotherapy for refractory metastatic colorectal cancer: A pilot study from South India
KC Lakshmaiah, Tamojit Chaudhuri, Govind K Babu, Dasappa Lokanatha, Linu Abraham Jacob, MC Suresh Babu, AH Rudresha, KN Lokesh, LK Rajeev
October-December 2017, 54(4):631-633
DOI:10.4103/ijc.IJC_374_17  PMID:30082548
  - 949 119
GI ONCOLOGY/PATHOLOGY
Clinicopathologic characteristics of Wnt/β-catenin-deregulated hepatocellular carcinoma
Anuj Verma, Munita Bal, Mukta Ramadwar, Kedar Deodhar, Prachi Patil, Mahesh Goel
October-December 2017, 54(4):634-639
DOI:10.4103/ijc.IJC_655_17  PMID:30082549
  - 846 119
Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups
Paromita Roy, Jayati Datta, Manas Roy, Indranil Mallick, Mallath Mohandas
October-December 2017, 54(4):640-645
DOI:10.4103/ijc.IJC_642_17  PMID:30082550
  - 1,387 186
HEAD AND NECK/OUTCOMES
Total laryngectomy: Surgical morbidity and outcomes – A case series
Gouri H Pantvaidya, Sheetal Raina, Arindam Mondal, Anuja Deshmukh, Deepa Nair, Prathamesh Pai, Pankaj Chaturvedi, Anil D'Cruz
October-December 2017, 54(4):621-625
DOI:10.4103/ijc.IJC_463_17  PMID:30082546
  - 1,274 140
IMAGING
Radiological diagnosis alone risks overtreatment of benign disease in suspected gallbladder cancer: A word of caution in an era of radical surgery
Shraddha Patkar, Rajesh S Shinde, Sagar R Kurunkar, Devayani Niyogi, Nitin S Shetty, Mukta Ramadwar, Mahesh Goel
October-December 2017, 54(4):681-684
DOI:10.4103/ijc.IJC_516_17  PMID:30082558
  - 937 114
MESSAGE FROM THE EDITORS
Where are the letter writers? And the referees?

October-December 2017, 54(4):591-591
DOI:10.4103/0019-509X.237912  PMID:30082539
  - 864 177
OFF THE BEATEN TRACK
Dr. Ranjana Srivastava – oncologist extraordinaire
Sunil K Pandya
October-December 2017, 54(4):701-701
DOI:10.4103/ijc.IJC_384_18  PMID:30082564
  - 673 122
PEDIATRIC HEMATOLOGY/OUTCOMES
Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital
Gaurav Narula, Maya Prasad, Shalini Jatia, Papagudi G Subramanian, Nikhil Patkar, Prashant Tembhare, Dhanlaxmi Shetty, Nehal Khanna, Siddharth Laskar, Tanuja Shet, Sridhar Epari, Seema Kembhavi, Sneha Shah, Sajid Qureshi, Sumeet Gujral, Shripad D Banavali
October-December 2017, 54(4):609-615
DOI:10.4103/ijc.IJC_487_17  PMID:30082544
  - 1,561 136
UROLOGY/MEDICAL ONCOLOGY
First-line tyrosine kinase inhibitors in metastatic renal cell carcinoma: A regional cancer center experience
AH Rudresha, Tamojit Chaudhuri, KC Lakshmaiah, Govind K Babu, D Lokanatha, Linu Abraham Jacob, MC Suresh Babu, KN Lokesh, LK Rajeev
October-December 2017, 54(4):626-630
DOI:10.4103/ijc.IJC_380_17  PMID:30082547
  - 1,167 168
UROLOGY/OUTCOMES
Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India
Amit Joshi, Amitesh Anand, Kumar Prabhash, Vanita Noronha, Sameer Shrirangwar, Ganesh Bakshi, Mahendra Pal, Vedang Murthy, Rahul Krishnatry, Sangeeta Desai, Santosh Menon, Deepali Patil, Sheetal Kulkarni, Nilesh Sable, Palak Popat, Archi Agrawal, Venkatesh Rangarajan, Gagan Prakash
October-December 2017, 54(4):601-604
DOI:10.4103/ijc.IJC_644_17  PMID:30082542
  - 1,435 164
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow